Page last updated: 2024-10-26

ethosuximide and Nephrotic Syndrome

ethosuximide has been researched along with Nephrotic Syndrome in 1 studies

Ethosuximide: An anticonvulsant especially useful in the treatment of absence seizures unaccompanied by other types of seizures.
ethosuximide : A dicarboximide that is pyrrolidine-2,5-dione in which the hydrogens at position 3 are substituted by one methyl and one ethyl group. An antiepileptic, it is used in the treatment of absence seizures and may be used for myoclonic seizures, but is ineffective against tonic-clonic seizures.

Nephrotic Syndrome: A condition characterized by severe PROTEINURIA, greater than 3.5 g/day in an average adult. The substantial loss of protein in the urine results in complications such as HYPOPROTEINEMIA; generalized EDEMA; HYPERTENSION; and HYPERLIPIDEMIAS. Diseases associated with nephrotic syndrome generally cause chronic kidney dysfunction.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Silverman, SH1
Gribetz, D1
Rausen, AR1

Other Studies

1 other study available for ethosuximide and Nephrotic Syndrome

ArticleYear
Nephrotic syndrome associated with ethosuccimide.
    American journal of diseases of children (1960), 1978, Volume: 132, Issue:1

    Topics: Child; Ethosuximide; Female; Humans; Nephrotic Syndrome

1978